Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2719
Gene Symbol: GPC3
GPC3
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 201294
Gene Symbol: UNC13D
UNC13D
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 79158
Gene Symbol: GNPTAB
GNPTAB
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 2629
Gene Symbol: GBA
GBA
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 3020
Gene Symbol: H3-3A
H3-3A
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 3073
Gene Symbol: HEXA
HEXA
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 5551
Gene Symbol: PRF1
PRF1
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 85444
Gene Symbol: LRRCC1
LRRCC1
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 1962
Gene Symbol: EHHADH
EHHADH
0.010 GeneticVariation phenotype LHGDN Pathology of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation. 9185222 1997
Entrez Id: 5184
Gene Symbol: PEPD
PEPD
0.400 Biomarker phenotype HPO
Entrez Id: 9719
Gene Symbol: ADAMTSL2
ADAMTSL2
0.400 Biomarker phenotype HPO
Entrez Id: 4591
Gene Symbol: TRIM37
TRIM37
0.400 Biomarker phenotype HPO
Entrez Id: 5184
Gene Symbol: PEPD
PEPD
0.400 Biomarker phenotype CTD_human A nonsense mutation of PEPD in four Amish children with prolidase deficiency. 16470701 2006
Entrez Id: 1535
Gene Symbol: CYBA
CYBA
0.400 Biomarker phenotype CTD_human Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models. 28108177 2017
Entrez Id: 55315
Gene Symbol: SLC29A3
SLC29A3
0.400 Biomarker phenotype HPO
Entrez Id: 4591
Gene Symbol: TRIM37
TRIM37
0.400 Biomarker phenotype CTD_human Mulibrey nanism: clinical features and diagnostic criteria. 14757854 2004
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.400 Biomarker phenotype CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 1535
Gene Symbol: CYBA
CYBA
0.400 Biomarker phenotype HPO
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.400 Biomarker phenotype HPO
Entrez Id: 9719
Gene Symbol: ADAMTSL2
ADAMTSL2
0.400 Biomarker phenotype CTD_human ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation. 18677313 2008
Entrez Id: 55315
Gene Symbol: SLC29A3
SLC29A3
0.400 Biomarker phenotype CTD_human Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease. 20140240 2010
Entrez Id: 8856
Gene Symbol: NR1I2
NR1I2
0.300 Biomarker phenotype CTD_human An integrated approach for prospectively investigating a mode-of-action for rodent liver effects. 23607986 2013
Entrez Id: 1543
Gene Symbol: CYP1A1
CYP1A1
0.300 Biomarker phenotype CTD_human Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models. 28108177 2017
Entrez Id: 246329
Gene Symbol: STAC3
STAC3
0.300 Biomarker phenotype CTD_human Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models. 28108177 2017
Entrez Id: 1
Gene Symbol: A1BG
A1BG
0.300 Biomarker phenotype CTD_human Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models. 28108177 2017